Changes

<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] -->Apligraf is a synthetic skin created from harvested foreskins.<ref>{{Construction SiteREFwebQuote | quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | last= | first= | publisher=Organogenesis | year= | urltitle=Apligraf: How Is It Made? | url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | accessdate=2011-03-06}}</ref> It is [[FDA]] approved,<ref>{{REFwebQuote | quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | last= | first= | publisher=Organogenesis | year= | urltitle=Apligraf | url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | accessdate=2011-03-06}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.

[[Image:Alloderm-logo.jpg|right|thumb|]]Apligraf is a synthetic skin created from harvested foreskins.<ref>{{cite web | url = http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | title = Apligraf: How Is It Made? | accessdate Apligraph Oral = 2011-03-06 | publisher = Organogenesis | quote = Human keratinocytes and fibroblasts are derived from neonatal foreskins}}</ref> It is [[FDA]] approved,<ref>{{cite web | url = http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | title = Apligraf | accessdate = 2011-03-06 | publisher = Organogenesis | quote = Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.

==Apligraph Oral== Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref> {{cite web REFnews | last= | first= | coauthors= | url = http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | title = November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | date=November 2011 | publisher=FDA | quote= | accessdate = 2011-12-20 | date = November 2011}}</ref>